Dose Rationalization of Pembrolizumab and Nivolumab Using Pharmacokinetic Modeling and Simulation and Cost Analysis
Kayode Ogungbenro; Alkesh Patel; Robert Duncombe; Richard Nuttall; James Clark; Paul Lorigan
Author Information: Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.